STOCK TITAN
  1. Home
  2. Sec-filings
  3. ALHC
  4. [Form 4] Alignment Healthcare, Inc. Insider Trading Activity

Alignment Healthcare (NASDAQ: ALHC) legal chief sells 30,939 shares, holds 343,592

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Alignment Healthcare, Inc. reports that Chief Legal and Admin. Officer Christopher J. Joyce sold a total of 30,939 shares of common stock on September 10, 2025 in transactions reported as sales in the open market or private transactions at weighted-average prices around $16 per share. After these sales, he directly holds 343,592 shares. A contextual footnote notes that some shares were required to be sold to cover tax withholding obligations related to restricted stock unit vesting and were not discretionary trades.

Positive

  • None.

Negative

  • None.

Insights

TL;DR Insider sold shares to cover tax withholding from RSU vesting; transactions appear non-discretionary and routine.

The Form 4 shows Mr. Joyce executed two sales on 09/10/2025 that he identifies as sales to satisfy tax withholding obligations tied to restricted stock unit vesting. The filing discloses weighted-average sale prices and price ranges for the multiple underlying trades, and retains detailed beneficial ownership counts after the sales. For investors, this is a common administrative sale rather than an indicated change in strategic ownership. The disclosure and willingness to provide transaction-level pricing on request improve transparency.

TL;DR Reporting is compliant and transparent; nature of sale reduces governance concern.

The report identifies the reporting persons role and relationship to the issuer and clearly states the sales were to cover tax withholding from vested RSUs, a typical practice. The inclusion of weighted-average prices and price ranges, plus an undertaking to provide per-trade details on request, meets disclosure expectations. There is no indication of discretionary trading activity or unusual timing in the filing itself.

Insider JOYCE CHRISTOPHER J
Role Chief Legal and Admin. Officer
Sold 30,939 shs ($508K)
Type Security Shares Price Value
Sale Common Stock 22,128 $16.2293 $359K
Sale Common Stock 8,811 $16.8555 $149K
Holdings After Transaction: Common Stock — 343,592 shares (Direct)
Footnotes (3)
  1. F1. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.
  2. F2. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.74 to $16.735. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
  3. F3. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.74 to $17.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
Total shares sold 30,939 shares Aggregate common stock sold by Christopher J. Joyce on September 10, 2025
First sale tranche 22,128 shares Common stock sold at $16.2293 per share on September 10, 2025
Second sale tranche 8,811 shares Common stock sold at $16.8555 per share on September 10, 2025
Post-transaction holdings 343,592 shares Direct common stock holdings of Christopher J. Joyce after reported transactions
Price range tranche 1 $15.74–$16.735 per share Weighted-average price range for one set of reported sales
Price range tranche 2 $16.74–$17.24 per share Weighted-average price range for another set of reported sales
restricted stock units financial
"in connection with the vesting of restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
weighted-average price financial
"The reported price in column 4 is a weighted-average price."
Weighted-average price is the average of multiple prices where each price is counted according to its size or importance—larger trades carry more weight than smaller ones, like averaging course grades by credit hours. It matters to investors because it gives a more realistic picture of the true price paid or received, helping assess trade execution, compare performance, calculate cost basis, and value positions more accurately than a simple average.
tax withholding obligations financial
"required to be sold by the reporting person to cover tax withholding obligations"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

How many Alignment Healthcare (ALHC) shares did Christopher J. Joyce sell on September 10, 2025?
Christopher J. Joyce sold 30,939 shares of Alignment Healthcare common stock on September 10, 2025, in two transactions reported as open-market or private sales. One tranche was 22,128 shares at $16.2293 per share and another was 8,811 shares at $16.8555 per share.

At what prices were the ALHC shares sold by Christopher J. Joyce?
The reported weighted-average sale prices were $16.2293 and $16.8555 per share across multiple trades. Footnotes state individual trades occurred within ranges of $15.74–$16.735 and $16.74–$17.24, with full price details available to security holders upon request.

What is Christopher J. Joyce’s role at Alignment Healthcare (ALHC)?
Christopher J. Joyce is Alignment Healthcare’s Chief Legal and Admin. Officer. The Form 4 indicates he is an officer but not a director and not a ten percent owner, highlighting his executive legal and administrative role rather than board membership or large-shareholder status.

How many Alignment Healthcare (ALHC) shares does Christopher J. Joyce hold after the reported sales?
After the September 10, 2025 transactions, Christopher J. Joyce directly holds 343,592 shares of Alignment Healthcare common stock. This canonical post-transaction balance reflects his remaining equity stake following the disclosed sale of 30,939 shares.

Were Christopher J. Joyce’s ALHC share sales discretionary trades?
A footnote explains that certain shares were required to be sold to cover tax withholding obligations from restricted stock unit vesting and were not discretionary trades. The transactions themselves are coded as sales of common stock in open-market or private transactions on the Form 4.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
JOYCE CHRISTOPHER J
(Last) (First) (Middle)
1100 W. TOWN & COUNTRY RD.
SUITE 1600
(Street)
ORANGE CA 92868
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Legal and Admin. Officer
3. Date of Earliest Transaction (Month/Day/Year)
09/10/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/10/2025 S 22,128(1) D $16.2293(2) 352,403 D
Common Stock 09/10/2025 S 8,811(1) D $16.8555(3) 343,592 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.
2. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.74 to $16.735. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
3. The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.74 to $17.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
Remarks:
/s/ Christopher J. Joyce 09/10/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR